• الأردن: 00962781409934 - 00962778455550 - 00962791066457, الإمارات: 00971564999475 - 00971501299947 - 00971564880709
  • الجزائر: 0549996833, تونس: 0021695451643, بريطانيا و أوروبا: 00441902871854 - 00447519398225 - 00447517362128 - 00447519398239
  • تركيا: 00905539440472, أمريكا و كندا: 0017735728151 - 0017736162627 - 0018472850055
  • العراق: 07733000696 - 07733598900

أضخم موقع علمي صحي موثق في العالم لسعادة العائلة وصحتها, بالعلم والإيمان نبني الميزان

100893940

ab colostrum and Autism

ab colostrum and Autism










Details

Divisions/Titles for AbstractNo.

Autistic disorder and phospholipids: A review.

Abstract Title

1

Prostaglandins, Leukotrienes and Essential Fatty Acids, 84, 25-30.

Abstract Source

2

Brown, C. M. & Austin, D. W. 

Abstract Author(s)

3

Swinburne Autism Bio-Research Initiative (SABRI), Faculty of Life and Social Sciences, Swinburne .University of Technology, Hawthorn, Victoria 3122, Australia.

Article Affiliation

4

Dysregulated phospholipid metabolism has been proposed as an underlying biological component of neurodevelopmental disorders such as autistic disorder (AD) and attention-deficit/hyperactivity disorder (ADHD). This review provides an overview of fatty acid and phospholipid metabolism and evidence for phospholipid dysregulation with reference to the membrane hypothesis of schizophrenia. While there is evidence that phospholipid metabolism is at least impaired in individuals with AD, it has not been established whether phospholipid metabolism is implicated in causal, mechanistic or epiphenomenological models. More research is needed to ascertain whether breastfeeding, and specifically, the administration of colostrum or an adequate substitute can play a preventative role by supplying the neonate with essential fatty acids (EFAs) at a critical juncture in their development. Regarding treatment, further clinical trials of EFA supplementation are essential to determine the efficacy of EFAs in reducing AD symptomatology and whether supplementation can serve as a cost-effective and readily available intervention.

Abstract

5

The administration of colostrum or an adequate substitute can play a preventative role by supplying the neonate with essential fatty acids (EFAs) at a critical juncture in their development. EFA supplementation are essential to determine the efficacy of EFAs in reducing AD symptomatology.The active substances found in high quality first milking bovine colostrum may afford significant benefits to individuals with autism spectrum disorders.The strong correlation of gastrointestinal symptoms with autism severity indicates that children with more severe autism are likely to have more severe gastrointestinal symptoms and vice versa.Secretory IgA (sIgA) is the major immunoglobulin in colostrum and gastrointestinal secretions . It plays a major role in preventing adherence of microorganisms to mucosal sites, in activating the alternative complement pathway, and in activating inflammatory reactions.

Summary

6

10/01/2011

Article Published Date

7

Review

Study Type

8

colostrum

Substances

9

Autism

Diseases

10

Autism management.

Pharmacological Actions

11

https://goo.gl/2R5Xru

Link

12







videos balancecure


شاركها مع اصدقائك



اشترك بالقائمة البريدية


التعليقات

لا يوجد تعليقات

أضف تعليقًا

Made with by Tashfier

loading gif
feedback